Yi‐An Cheng

566 total citations
17 papers, 413 citations indexed

About

Yi‐An Cheng is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yi‐An Cheng has authored 17 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Biomaterials and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yi‐An Cheng's work include Nanoparticle-Based Drug Delivery (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Yi‐An Cheng is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Yi‐An Cheng collaborates with scholars based in Taiwan, United Kingdom and China. Yi‐An Cheng's co-authors include Tian‐Lu Cheng, Yun‐Chi Lu, I‐Ju Chen, Jing Liu, Shi Liu, Qiu Zhao, Meng Zhang, Zhou Zhou, Kai-Wen Cheng and Yinan Jiang and has published in prestigious journals such as Analytical Chemistry, Scientific Reports and PLoS Biology.

In The Last Decade

Yi‐An Cheng

17 papers receiving 405 citations

Peers

Yi‐An Cheng
Shanshan Qin China
Jinhai Tang China
Hailing Tang China
Yun‐Chi Lu Taiwan
Jiayi Lin China
Yuwen Xie China
Yufan Xiang China
Linghao Zhao China
Shanshan Qin China
Yi‐An Cheng
Citations per year, relative to Yi‐An Cheng Yi‐An Cheng (= 1×) peers Shanshan Qin

Countries citing papers authored by Yi‐An Cheng

Since Specialization
Citations

This map shows the geographic impact of Yi‐An Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐An Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐An Cheng more than expected).

Fields of papers citing papers by Yi‐An Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐An Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐An Cheng. The network helps show where Yi‐An Cheng may publish in the future.

Co-authorship network of co-authors of Yi‐An Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐An Cheng. A scholar is included among the top collaborators of Yi‐An Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐An Cheng. Yi‐An Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Cheng, Yi‐An, I‐Ju Chen, Chiao‐Yun Chen, et al.. (2023). Targeting and internalizing PEGylated nanodrugs to enhance the therapeutic efficacy of hematologic malignancies by anti-PEG bispecific antibody (mPEG × CD20). Cancer Nanotechnology. 14(1). 13 indexed citations
3.
Lin, Wen-Wei, et al.. (2021). Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy. Scientific Reports. 11(1). 7598–7598. 7 indexed citations
4.
Lin, Wen-Wei, Yun‐Chi Lu, Chih-Hung Chuang, et al.. (2021). Selective activation of pro-anti-IL-1β antibody enhances specificity for autoinflammatory disorder therapy. Scientific Reports. 11(1). 14846–14846. 10 indexed citations
5.
Chen, Michael, Ming‐Thau Sheu, Steve R. Roffler, et al.. (2021). A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor. Biomaterials Science. 10(1). 202–215. 11 indexed citations
6.
Chen, Yen‐Cheng, Zhi‐Feng Miao, Yi‐An Cheng, et al.. (2020). Gut Fecal Microbiota Transplant in a Mouse Model of Orthotopic Rectal Cancer. Frontiers in Oncology. 10. 568012–568012. 10 indexed citations
7.
Cheng, Yi‐An, Yun‐Ming Wang, Tian‐Lu Cheng, et al.. (2020). Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer. Journal of Nanobiotechnology. 18(1). 118–118. 13 indexed citations
8.
Chen, I‐Ju, Yi‐An Cheng, Wen-Wei Lin, et al.. (2020). Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes. Acta Biomaterialia. 111. 386–397. 21 indexed citations
9.
Cheng, Kai-Wen, Yuan-Chin Hsieh, Wen-Wei Lin, et al.. (2019). Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein. Scientific Reports. 9(1). 9931–9931. 8 indexed citations
10.
Cheng, Yi‐An, I‐Ju Chen, Yu-Cheng Su, et al.. (2019). Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer. Biomaterials Science. 7(8). 3404–3417. 28 indexed citations
11.
Lu, Yun‐Chi, Chih-Hung Chuang, Kuo‐Hsiang Chuang, et al.. (2019). Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLoS Biology. 17(6). e3000286–e3000286. 26 indexed citations
12.
Cheng, Kai-Wen, Chih-Hua Tseng, Cherng‐Chyi Tzeng, et al.. (2018). Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo. Pharmacological Research. 139. 41–49. 73 indexed citations
13.
Zhou, Zhou, Yi‐An Cheng, Yinan Jiang, et al.. (2018). Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis. International Journal of Biological Sciences. 14(2). 124–136. 115 indexed citations
14.
Lin, Wen-Wei, Yi‐An Cheng, Chien-Han Kao, et al.. (2017). Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules. Analytical Chemistry. 89(11). 6082–6090. 12 indexed citations
15.
Chen, I‐Ju, Chih-Hung Chuang, Yuan-Chin Hsieh, et al.. (2017). Selective antibody activation through protease-activated pro-antibodies that mask binding sites with inhibitory domains. Scientific Reports. 7(1). 36 indexed citations
16.
Lin, Wen-Wei, Yuan-Chin Hsieh, Yi‐An Cheng, et al.. (2016). Optimization of an Anti-poly(ethylene glycol) (anti-PEG) Cell-Based Capture System To Quantify PEG and PEGylated Molecules. Analytical Chemistry. 88(24). 12371–12379. 18 indexed citations
17.
Ho, Kuen‐Yao, et al.. (1997). Liposomes-coated hydroxyapatite and tricalcium phosphate implanted in the mandibular bony defect of miniature swine.. PubMed. 13(4). 213–28. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanshan Qin Breakdown of academic impact, for papers by Jinhai Tang Breakdown of academic impact, for papers by Hailing Tang Breakdown of academic impact, for papers by Yun‐Chi Lu Breakdown of academic impact, for papers by Jiayi Lin Breakdown of academic impact, for papers by Yuwen Xie Breakdown of academic impact, for papers by Yufan Xiang Breakdown of academic impact, for papers by Linghao Zhao
Rankless by CCL
2026